Kelly Shi
Stock Analyst at Jefferies
(2.89)
# 1,517
Out of 5,124 analysts
34
Total ratings
42.42%
Success rate
11.52%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Maintains: Buy | $8 → $9 | $1.98 | +354.55% | 2 | Dec 12, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $73 → $122 | $77.81 | +56.79% | 2 | Dec 9, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $63 → $77 | $75.96 | +1.37% | 4 | Oct 28, 2025 | |
| INSM Insmed | Maintains: Buy | $129 → $148 | $174.04 | -14.96% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $35.52 | -21.17% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $17.49 | +151.57% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $7.72 | +94.30% | 1 | Apr 10, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $11.00 | +372.73% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $5.40 | +159.26% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $25.01 | -24.03% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $174 → $196 | $213.24 | -8.08% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $4.29 | +389.51% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $21.01 | +76.11% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $2.24 | +167.86% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $98.77 | -17.99% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $20.12 | +73.96% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.19 | +1,543.84% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $13.18 | +21.40% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $15.68 | +27.55% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $432 | $8.42 | +5,030.64% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $13.33 | +290.10% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $2.82 | +857.45% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $1.89 | +1,646.03% | 1 | Mar 8, 2021 |
ImmunityBio
Dec 12, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $1.98
Upside: +354.55%
Kymera Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $73 → $122
Current: $77.81
Upside: +56.79%
PTC Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $63 → $77
Current: $75.96
Upside: +1.37%
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $174.04
Upside: -14.96%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $35.52
Upside: -21.17%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $17.49
Upside: +151.57%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $7.72
Upside: +94.30%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $11.00
Upside: +372.73%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $5.40
Upside: +159.26%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $25.01
Upside: -24.03%
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $213.24
Upside: -8.08%
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $4.29
Upside: +389.51%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $21.01
Upside: +76.11%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $2.24
Upside: +167.86%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $98.77
Upside: -17.99%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $20.12
Upside: +73.96%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $2.19
Upside: +1,543.84%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $13.18
Upside: +21.40%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $15.68
Upside: +27.55%
Mar 4, 2022
Initiates: Buy
Price Target: $432
Current: $8.42
Upside: +5,030.64%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $13.33
Upside: +290.10%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $2.82
Upside: +857.45%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $1.89
Upside: +1,646.03%